Free Newsletter
Individual investors buy into vaccination bond issue
Japanese investors have snapped up a $223 million bond program to fund vaccination campaigns in developing countries. The idea is that the investors' money will be used to pay for the upfront costs of a campaign and they will be repaid as governments fund the programs. This is the first time that individual investors have bought into a vaccination bond program and it could prove a model for future fundraising efforts in other countries.
In this case, Japanese investors paid as little as $1,270 to buy into the issue from the International Finance Facility for Immunization. In 2006 the first IFFim bond raised $1 billion from institutions in London and underwritten by a group of countries including the UK.
- read the report from the Financial TimesĀ
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A; Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


